Doctor profile · Federal record
Dr. Tarek Mousa, MD, PHD
Cardiovascular Disease Physician (CMS: Internal Medicine) · Astoria, NY
- NPI 1013177757
- Accepts Medicare
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2427 Steinway St
Astoria, NY 111033654
(929) 208-0080
fax (929) 208-0010
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- September 16, 2020
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- New York #259363
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1013177757. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
530
Distinct HCPCS
10
Medicare allowed
$74,579
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2785 |
Injection, regadenoson, 0.1 mg | 132 | 32 | $58 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 77 | 39 | $105 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 66 | 32 | $120 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 65 | 36 | $148 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 45 | 38 | $17 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 34 | 33 | $71 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 33 | 32 | $526 | |
99152 |
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 28 | 21 | $14 | |
92928 |
Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 19 | 12 | $650 | |
93458 |
Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 18 | 18 | $281 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 789. This provider delivers 0.7× the peer median.Open Payments
Industry payments received
All-time total
$270
Transactions
9
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 4 | $127.54 | |
| Kestra Medical Technology Services, Inc. | 1 | $40.00 | |
| Merck Sharp & Dohme LLC | 1 | $32.92 | |
| Alnylam Pharmaceuticals Inc. | 1 | $25.28 | |
| Novartis Pharmaceuticals Corporation | 1 | $25.00 | |
| AstraZeneca Pharmaceuticals LP | 1 | $19.06 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
697
Patients
167
Total drug cost
$56,149
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ranolazine Er (Ranolazine) | Brand | 129 | 35 | $23,185 |
| Amlodipine Besylate | Generic | 96 | 36 | $1,512 |
| Atorvastatin Calcium | Generic | 87 | 31 | $2,573 |
| Metoprolol Succinate | Generic | 65 | 26 | $1,673 |
| Losartan Potassium | Generic | 61 | 19 | $1,854 |
| Rosuvastatin Calcium | Generic | 56 | 20 | $2,018 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 35 | 0 | $1,117 |
| Hydrochlorothiazide | Generic | 30 | 0 | $115 |
| Lisinopril | Generic | 29 | 0 | $1,025 |
| Losartan-Hydrochlorothiazide (Losartan/Hydrochlorothiazide) | Brand | 26 | 0 | $831 |
Hospital affiliations
Frequently asked questions
What is Dr. Tarek Mousa's medical specialty?
Dr. Tarek Mousa practices Cardiovascular Disease Physician in Astoria, NY.
Where does Dr. Tarek Mousa practice?
Dr. Tarek Mousa practices at 2427 Steinway St, Astoria, NY 111033654. Office phone: 9292080080.
What is Dr. Tarek Mousa's NPI?
Dr. Tarek Mousa's National Provider Identifier (NPI) is 1013177757, issued by NPPES.
Does Dr. Tarek Mousa accept Medicare assignment?
Yes. Dr. Tarek Mousa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tarek Mousa commonly perform?
Top Medicare-reported procedures in 2023: Injection, regadenoson, 0.1 mg (HCPCS J2785); Established patient office or other outpatient visit (HCPCS 99213); Technetium tc-99m sestamibi, diagnostic, per study dose (HCPCS A9500). Source: CMS Medicare Physician & Other Practitioners file.